NL-OMON53002已完成不适用
Tailored treatment in Older Patients TOP-1: Omission of radiotherapy in elderly patients with low risk breast cancer - TOP-1
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •- age 70 years and older;
- •- after breast conserving surgery
- •- tumor <1cm grade 1-2 or tumor 1-2cm grade 1;
- •- tumor ER>50% positive, HER2 negative;
- •- sN0 or sN0(itc);
- •- R0 resection;
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •- indication for hormonal therapy;
- •- bilateral.
研究者
相似试验
进行中（未招募）
4 期
Optimising prescription of treatment in older patients with mild hypertension (high blood pressure) at increased risk of serious adverse eventsCirculatory SystemHypertensionISRCTN18030225niversity of Oxford3,014
进行中（未招募）
不适用
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMMedDRA version: 16.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2013-001473-24-DEEli Lilly and Company880
进行中（未招募）
不适用
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMDiabetes Mellitus, Type 2MedDRA version: 17.0Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 100000004861EUCTR2013-001473-24-ATEli Lilly and Company880
进行中（未招募）
1 期
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMDiabetes Mellitus, Type 2EUCTR2013-001473-24-GBEli Lilly and Company880
招募中
不适用
Efficacy of the CARG Toxicity Score versus clinician estimate for predicting the risk of chemotherapy toxicity in older adults with cancer.cancerACTRN12616000987460Dr Erin Moth150